All products are for Professional Use Only (PUO) — not intended for human or animal consumption

Back to Learn
Growth Hormone & PerformancePeptide

CJC-1295 w/ DAC

A synthetic growth hormone-releasing hormone (GHRH) analog conjugated with a Drug Affinity Complex (DAC) that extends its half-life to approximately 6-8 days. Studies have investigated its ability to sustain elevated growth hormone and IGF-1 levels.

Mechanism of Action

CJC-1295 with DAC is a 30-amino acid GHRH analog (tetrasubstituted GRF 1-29) covalently attached to a maleimidopropionic acid-based Drug Affinity Complex. Upon subcutaneous injection, the DAC moiety forms a covalent bond with circulating albumin via a reactive thiol, dramatically extending the peptide's plasma half-life from minutes to approximately 6-8 days. This allows sustained activation of the GHRH receptor on pituitary somatotrophs, producing prolonged elevation of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels without the sharp pulsatile pattern seen with native GHRH.

Research Applications

  • Studies have investigated sustained GH and IGF-1 elevation over multi-day periods
  • Research has examined body composition effects in growth hormone-deficient models
  • Studies have assessed pharmacokinetics and dose-response relationships
  • Studies have explored its relevance to age-related GH decline research

Key Published Studies

1

Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.

Key finding: Research investigated the pharmacokinetic and pharmacodynamic profile of CJC-1295 DAC, observing dose-dependent modulation of GH and IGF-1 signaling pathways that persisted over an extended duration.

2

Ionescu M, et al. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797.

Key finding: Despite continuous GHRH receptor stimulation, pulsatile GH secretion patterns were maintained, suggesting that CJC-1295 DAC preserves physiological GH release dynamics.

Research Use Only (RUO): This page summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. The compound described carries a Research Use Only designation and is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in the diagnosis, treatment, cure, or prevention of any disease. Consult qualified professionals before making any health-related decisions.

i2b Health Research Supply
RESEARCH USE ONLY

Age Verification Required

You must be 21 years of age or older to access this website. All products are intended for qualified researchers and laboratory use only.

By entering this site, you confirm that you are at least 21 years of age, that anything you acquire here is for research purposes, and that you agree to our Terms of Service and Research Use Only policy. Products are not intended for human or animal consumption.